These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15700919)

  • 1. Activation of platelets exposed to shear stress in the presence of smoke extracts of low-nicotine and zero-nicotine cigarettes: the protective effect of nicotine.
    Ramachandran J; Rubenstein D; Bluestein D; Jesty J
    Nicotine Tob Res; 2004 Oct; 6(5):835-41. PubMed ID: 15700919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions.
    Rubenstein D; Jesty J; Bluestein D
    Circulation; 2004 Jan; 109(1):78-83. PubMed ID: 14691035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations.
    Hom S; Chen L; Wang T; Ghebrehiwet B; Yin W; Rubenstein DA
    Platelets; 2016 Nov; 27(7):694-702. PubMed ID: 27096416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced-nicotine cigarettes increase platelet activation in smokers in vivo: a dilemma in harm reduction.
    Girdhar G; Xu S; Bluestein D; Jesty J
    Nicotine Tob Res; 2008 Dec; 10(12):1737-44. PubMed ID: 18982536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro model of platelet-endothelial activation due to cigarette smoke under cardiovascular circulation conditions.
    Girdhar G; Xu S; Jesty J; Bluestein D
    Ann Biomed Eng; 2008 Jul; 36(7):1142-51. PubMed ID: 18452059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts.
    Ouyang Y; Virasch N; Hao P; Aubrey MT; Mukerjee N; Bierer BE; Freed BM
    J Allergy Clin Immunol; 2000 Aug; 106(2):280-7. PubMed ID: 10932071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between mainstream and sidestream tobacco smoke extracts and nicotine in the activation and aggregation of platelets subjected to cardiovascular conditions in diabetes.
    Yin W; Rubenstein DA
    Diab Vasc Dis Res; 2013 Jan; 10(1):57-64. PubMed ID: 22610271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low nicotine content cigarettes on smoke intake.
    Rose J; Behm F
    Nicotine Tob Res; 2004 Apr; 6(2):309-19. PubMed ID: 15203805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of tar, nicotine, and carbon monoxide yields in the smoke of bidi cigarettes.
    Watson CH; Polzin GM; Calafat AM; Ashley DL
    Nicotine Tob Res; 2003 Oct; 5(5):747-53. PubMed ID: 14577991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study by electron paramagnetic resonance of free radical species in the mainstream and sidestream smoke of cigarettes with conventional acetate filters and 'bio-filters'.
    Valavanidis A; Haralambous E
    Redox Rep; 2001; 6(3):161-71. PubMed ID: 11523591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes.
    Djordjevic MV; Fan J; Ferguson S; Hoffmann D
    Carcinogenesis; 1995 Sep; 16(9):2015-21. PubMed ID: 7554048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoke constituent exposure and smoking topography of adolescent daily cigarette smokers.
    Wood T; Wewers ME; Groner J; Ahijevych K
    Nicotine Tob Res; 2004 Oct; 6(5):853-62. PubMed ID: 15700921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete compensation does not imply reduced harm: yields of 40 smoke toxicants per milligram nicotine in regular filter versus low-tar cigarettes in the 1999 Massachusetts Benchmark Study.
    Harris JE
    Nicotine Tob Res; 2004 Oct; 6(5):797-807. PubMed ID: 15700915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.
    Melikian AA; Djordjevic MV; Chen S; Richie J; Stellman SD
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1408-15. PubMed ID: 17627005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cigarette format and mouth-level exposure to tar and nicotine in smokers of Russian king-size cigarettes.
    Ashley M; Dixon M; Prasad K
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):430-7. PubMed ID: 25146962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of new de-nicotinized cigarettes.
    Pickworth WB; Fant RV; Nelson RA; Rohrer MS; Henningfield JE
    Nicotine Tob Res; 1999 Dec; 1(4):357-64. PubMed ID: 11072433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure.
    Fischer S; Spiegelhalder B; Preussmann R
    IARC Sci Publ; 1991; (105):489-92. PubMed ID: 1855903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes.
    Adams JD; O'Mara-Adams KJ; Hoffmann D
    Carcinogenesis; 1987 May; 8(5):729-31. PubMed ID: 3581431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the mutagenicity of tobacco smoke from low-tar cigarettes.
    Chortyk OT; Chamberlain WJ
    Arch Environ Health; 1990; 45(4):237-44. PubMed ID: 2400246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry research on the use and effects of levulinic acid: a case study in cigarette additives.
    Keithly L; Ferris Wayne G; Cullen DM; Connolly GN
    Nicotine Tob Res; 2005 Oct; 7(5):761-71. PubMed ID: 16191747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.